Skip to main content
KOLON LIFE SCIENCE Inc. logo

KOLON LIFE SCIENCE Inc. — Investor Relations & Filings

Ticker · 102940 ISIN · KR7102940004 KO Manufacturing
Open in API
Filings indexed 294 across all filing types
Latest filing 2026-03-26 Capital/Financing Update
Country KR South Korea
Listing KO 102940

About KOLON LIFE SCIENCE Inc.

https://www.kolonls.co.kr/

KOLON LIFE SCIENCE Inc. is a company operating through two primary business divisions: Bio and Chemical. The Bio division is a clinical-stage biotechnology unit focused on developing novel cell and gene therapies, with a pipeline that includes treatments for neuropathic pain and oncolytic virus therapies for cancer. The Chemical division develops, manufactures, and sells Active Pharmaceutical Ingredients (APIs), specialty chemicals, antimicrobials, and water treatment solutions. The company leverages its expertise in both biotechnology and chemical manufacturing to provide advanced healthcare and environmental products.

Recent filings

Filing Released Lang Actions
특수관계인으로부터자금차입
Capital/Financing Update Classification · 1% confidence The document is an announcement of a financing transaction—a short-term loan from a related party detailing the amount, interest rate, borrowing period, board approval, and use of proceeds. This fits “Capital/Financing Update” rather than a full report or other regulatory filing type.
2026-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is the formal shareholders’ meeting results for the Annual General Meeting held on March 26, 2026, detailing voting outcomes on each agenda item (approval of financial statements, director elections, remuneration limits, etc.). This matches a Declaration of Voting Results (DVA) rather than the meeting notice or the full AGM materials.
2026-03-26 Korean
대표이사변경
Board/Management Information Classification · 1% confidence The document is an official announcement of a change in the company’s 대표이사 (CEO), including details of the outgoing and incoming executives, board resolution date, and related biographical information. This matches the definition for Board/Management Information (announcement of changes in the company's board of directors or senior management).
2026-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal notification to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, and mid-term resignation of outside directors. It details changes in the board of directors rather than financial results or other corporate actions. This aligns with "Board/Management Information" disclosures.
2026-03-26 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Kolon Life Science. It contains the auditor's opinion (적정/Unqualified), financial statements (consolidated and separate), and key financial metrics for the fiscal year ending 2025-12-31. While it provides financial data, it is specifically the regulatory filing of the audit report itself, which falls under the 'Audit Report / Information' category. FY 2025
2026-03-18 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Kolon Life Science, covering the fiscal year 2025. It includes the independent auditor's opinion, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. While it contains financial data, it is specifically the 'Audit Report' document type, which is distinct from a full Annual Report (10-K) or an Interim Report (IR). FY 2025
2026-03-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.